Cingulate Inc. (NASDAQ:CINGW) Sees Large Increase in Short Interest

Cingulate Inc. (NASDAQ:CINGW) was the recipient of a significant growth in short interest during the month of August. As of August 14th, there was short interest totaling 5,920 shares, a growth of 705.4% from the July 30th total of 735 shares. Based on an average daily trading volume, of 44,420 shares, the days-to-cover ratio is presently 0.1 days.

Cingulate Stock Down 38.9%

Cingulate stock traded down $0.00 during midday trading on Thursday, reaching $0.01. The company’s stock had a trading volume of 47,100 shares, compared to its average volume of 34,638. Cingulate has a fifty-two week low of $0.00 and a fifty-two week high of $0.12. The business has a 50-day simple moving average of $0.02 and a 200-day simple moving average of $0.03.

About Cingulate

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.